Management of Complications and Revisions of Sacral Neuromodulation

Chapter

Abstract

Despite the various treatment modalities available for patients with chronic lower urinary tract symptoms, sacral neuromodulation has proven to be a great minimally invasive option for those with refractory urinary retention, urgency incontinence, and overactive bladder symptoms. This procedure has undergone major changes since its inception in 1979, especially after the introduction of the tined lead. This chapter focuses on the complications of sacral neuromodulation and the different ways to troubleshoot them in order to improve therapeutic outcomes.

Keywords

Sacral Neuromodulation Tined Lead Percutaneous nerve evaluation (PNE) InterStim Implantable Pulse Generator IPG 

References

  1. 1.
    Oerlemans D, van Kerrebroeck P. Sacral nerve stimulation for neuromodulation of the lower urinary tract. Neurourol Urodyn. 2008;27:28–33.CrossRefGoogle Scholar
  2. 2.
    Kay GG, Abou-Donia MB, Messer WS Jr, et al. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc. 2005;53(12):2195–201.CrossRefGoogle Scholar
  3. 3.
    Bridgeman MB, Friia NJ, Taft C, et al. Mirabegron: β3-adrenergic receptor agonist for the treatment of overactive bladder. Ann Pharmacother. 2013;47(7–8):1029–38.CrossRefGoogle Scholar
  4. 4.
    Al-zahrani AA, Elzayat EA, Gajewski JB. Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center. J Urol. 2011;185:981–6.CrossRefGoogle Scholar
  5. 5.
    Banakhar M, Hassouna M. Percutaneous nerve evaluation test versus staged test trials for sacral neuromodulation: sensitivity, specificity, and predictive values of each technique. Int Neurourol J. 2016;20:250–4.CrossRefGoogle Scholar
  6. 6.
    Spinelli M, Giardiello G, Gerber M, et al. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol. 2003;70:1905–7.CrossRefGoogle Scholar
  7. 7.
    Bosch R, Groen J. Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study. J Urol. 2000;163:1219–22.CrossRefGoogle Scholar
  8. 8.
    Borawski KM, Foster RT, Webster GD. Predicting implantation with a neuromodulator using two different test stimulation techniques: a prospective randomized study in urge incontinent women. Neurourol Urodyn. 2007;26:14–8.CrossRefGoogle Scholar
  9. 9.
    Janknegt RA, Weil EH, Eerdmans PH. Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology. 1997;49:358–62.CrossRefGoogle Scholar
  10. 10.
    Peters K, Konstandt D. Complications of sacral neuromodulation. International Continence Society (abstract). https://www.ics.org/Abstracts/Publish/41/000174.pdf. Accessed 18 Sept 2017.
  11. 11.
    Sutherland SE, Lavers A, Carlson A, et al. Sacral nerve stimulation for voiding dysfunction: one institution’s 11-year experience. Neurourol Urodyn. 2007;26:19.CrossRefGoogle Scholar
  12. 12.
    Sievert KD, Matzel K, Ratto C, et al. Permanente sakrale Neuromodulation mittels InterStim1: Ergebnisseeiner Anwenderbefragung zu aktuellen technischen Entwicklungen. J Urol Urogynakol. 2007;14:14.Google Scholar
  13. 13.
    Siegel SW, Catanzaro F, Dijkema HE, et al. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology. 2000;56:87.CrossRefGoogle Scholar
  14. 14.
    Spinelli M, Giardiello G, Arduini A, et al. New percutaneous technique of sacral nerve stimulation has high initial success rate: preliminary results. Eur Urol. 2003;43:70–4.CrossRefGoogle Scholar
  15. 15.
    Hijaz A, Vasavada S. Complications and troubleshooting of sacral neuromodulation therapy. Urol Clin North Am. 2005;32:65–9.CrossRefGoogle Scholar
  16. 16.
    Deng DY, Gulati M, Rutman M, et al. Failure of sacral nerve stimulation due to migration of tined lead. J Urol. 2006;175(6):2182–5.CrossRefGoogle Scholar
  17. 17.
    Scheepens WA, Weil EH, van Koeveringe GA, et al. Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation—a multicenter study. Eur Urol. 2001;40:434.CrossRefGoogle Scholar
  18. 18.
    Van Kerrebroeck P, Van Voskuilen A, Lycklama A, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178:2029–34.CrossRefGoogle Scholar
  19. 19.
    Guralnick ML, Benouni S, O’Connor RC, et al. Characteristics of infections in patients undergoing staged implantation for sacral nerve stimulation. Urology. 2007;69(6):1073–6.CrossRefGoogle Scholar
  20. 20.
    Amend B, Bedke J, Khalil M, et al. Prolonged percutaneous SNM testing does not cause infection-related explanation. BJU Int. 2013;111(3):485–91.CrossRefGoogle Scholar
  21. 21.
    Haraway AM, Clemens JQ, He C, et al. Differences in sacral neuromodulation device infection rates based on preoperative antibiotic selection. Int Urogynecol J. 2013;24(12):2081–5.CrossRefGoogle Scholar
  22. 22.
    Kass-Iliyya A, Jenks J, Hamid R, et al. Tined lead versus percutaneous nerve evaluation for sacral nerve stimulator assessment. J Clin Urol. 2015;8(1):46–51.CrossRefGoogle Scholar
  23. 23.
    Vasavada SP, Rackley RR. Electrical stimulation and neuromodulation in storage and emptying failure. In: Wein AJ, Kavoussi LR, Partin AW, Peters CA, editors. eBook Campbell-Walsh urology. 11th ed. Philadelphia: Elsevier Health Sciences; 2015.Google Scholar
  24. 24.
    Hijaz A, Vasavada SP, Daneshgari F, et al. Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology. 2006;68(3):533–7.CrossRefGoogle Scholar
  25. 25.
    Carmel M, Vasavada SP, Goldman HB.Troubleshooting sacral neuromodulation issues. Curr Urol Rep. 2012;13:363–9.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Urology, Department of SurgeryAmerican University of Beirut Medical CenterBeirutLebanon
  2. 2.Center of Female Pelvic Medicine and Surgery, University Hospitals Cleveland Medical Center, Urology InstituteClevelandUSA

Personalised recommendations